Group 1 - The core viewpoint of the article highlights the financial performance and stock activity of Steady Medical (300888) as of February 24, 2026, with a closing price of 35.03 yuan, reflecting a 1.01% increase [1] - The company reported a main revenue of 7.897 billion yuan for the first three quarters of 2025, representing a year-on-year increase of 30.1%, and a net profit attributable to shareholders of 732 million yuan, up 32.36% year-on-year [2] - In the third quarter of 2025, the company achieved a single-quarter main revenue of 2.601 billion yuan, a 27.71% increase year-on-year, and a net profit of 240 million yuan, which is a 42.11% increase year-on-year [2] Group 2 - The company has a debt ratio of 33.87% and reported investment income of 33.23 million yuan, with financial expenses of -2.036 million yuan, and a gross profit margin of 48.32% [2] - Over the past 90 days, five institutions have provided ratings for the stock, with four buy ratings and one hold rating, and the average target price set by institutions is 5.207 billion yuan [2] - The main business of Steady Medical includes the research, production, and sales of cotton products, covering medical health, personal care, family care, maternal and infant care, and home textiles [2]

稳健医疗2025年三季报显示，前三季度公司主营收入78.97亿元，同比上升30.1%；归母净利润7.32亿 元，同比上升32.36%；扣非净利润6.79亿元，同比上升43.93%；其中2025年第三季度，公司单季度主营 收入26.01亿元，同比上升27.71%；单季度归母净利润2.4亿元，同比上升42.11%；单季度扣非净利润 2.18亿元，同比上升50.77%；负债率33.87%，投资收益3323.27万元，财务费用-203.6万元，毛利率 48.32%。稳健医疗（300888）主营业务：棉类制品的研发、生产、销售,覆盖医疗卫生、个人护理、家 庭护理、母婴护理、家纺服饰等。 证券之星消息，截至2026年2月11日收盘，稳健医疗(300888)报收于35.39元，下跌0.03%，换手率 0.33%，成交量1.92万手，成交额6808.36万元。 2月11日的资金流向数据方面，主力资金净流出1301.46万元，占总成交额19.12%，游资资金净流出 46.39万元，占总成交额0.68%，散户资金净流入1347.85万元，占总成交额19.8%。 近5日资金流向一览见下表： 该股主要指标及行业内排名如下： 该股最近 ...

Core Viewpoint - The company Steady Medical (300888) has shown significant growth in its financial performance for the first three quarters of 2025, with a notable increase in both revenue and net profit compared to the previous year [2]. Financial Performance - For the first three quarters of 2025, Steady Medical reported a total revenue of 7.897 billion yuan, representing a year-on-year increase of 30.1% [2]. - The net profit attributable to shareholders reached 732 million yuan, up 32.36% year-on-year [2]. - The company's net profit excluding non-recurring items was 679 million yuan, reflecting a 43.93% increase year-on-year [2]. - In the third quarter of 2025 alone, the company achieved a revenue of 2.601 billion yuan, which is a 27.71% increase compared to the same quarter last year [2]. - The net profit for the third quarter was 240 million yuan, marking a 42.11% year-on-year growth [2]. - The net profit excluding non-recurring items for the third quarter was 218 million yuan, showing a 50.77% increase year-on-year [2]. - The company's debt ratio stands at 33.87%, with investment income of 33.23 million yuan and financial expenses of -2.036 million yuan [2]. - The gross profit margin is reported at 48.32% [2]. Market Activity - As of February 9, 2026, Steady Medical's stock closed at 35.71 yuan, with a turnover rate of 0.57% and a trading volume of 33,400 hands, resulting in a transaction amount of 119 million yuan [1]. - On February 9, the net outflow of main funds was 8.6952 million yuan, accounting for 7.29% of the total transaction amount, while retail investors saw a net inflow of 15.475 million yuan, representing 12.97% of the total transaction amount [1]. Analyst Ratings - In the last 90 days, 10 institutions have provided ratings for Steady Medical, with 8 giving a "buy" rating and 2 giving a "hold" rating [2]. - The average target price set by institutions over the past 90 days is 5.451 billion yuan [2].

近5日资金流向一览见下表： 证券之星消息，截至2026年2月5日收盘，稳健医疗(300888)报收于35.87元，上涨0.82%，换手率 0.71%，成交量4.11万手，成交额1.48亿元。 2月5日的资金流向数据方面，主力资金净流入625.52万元，占总成交额4.24%，游资资金净流入1078.28 万元，占总成交额7.31%，散户资金净流出1703.8万元，占总成交额11.54%。 该股最近90天内共有11家机构给出评级，买入评级9家，增持评级2家；过去90天内机构目标均价为 54.51。 资金流向名词解释：指通过价格变化反推资金流向。股价处于上升状态时主动性买单形成的成交额是推 动股价上涨的力量，这部分成交额被定义为资金流入，股价处于下跌状态时主动性卖单产生的的成交额 是推动股价下跌的力量，这部分成交额被定义为资金流出。当天两者的差额即是当天两种力量相抵之后 剩下的推动股价上升的净力。通过逐笔交易单成交金额计算主力资金流向、游资资金流向和散户资金流 向。 注：主力资金为特大单成交，游资为大单成交，散户为中小单成交 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备3101043457103012 ...

资金流向名词解释：指通过价格变化反推资金流向。股价处于上升状态时主动性买单形成的成交额是推 动股价上涨的力量，这部分成交额被定义为资金流入，股价处于下跌状态时主动性卖单产生的的成交额 是推动股价下跌的力量，这部分成交额被定义为资金流出。当天两者的差额即是当天两种力量相抵之后 剩下的推动股价上升的净力。通过逐笔交易单成交金额计算主力资金流向、游资资金流向和散户资金流 向。 近5日资金流向一览见下表： 该股主要指标及行业内排名如下： 证券之星消息，截至2026年1月27日收盘，稳健医疗(300888)报收于37.0元，下跌1.62%，换手率 1.03%，成交量6.0万手，成交额2.21亿元。 稳健医疗2025年三季报显示，前三季度公司主营收入78.97亿元，同比上升30.1%；归母净利润7.32亿 元，同比上升32.36%；扣非净利润6.79亿元，同比上升43.93%；其中2025年第三季度，公司单季度主营 收入26.01亿元，同比上升27.71%；单季度归母净利润2.4亿元，同比上升42.11%；单季度扣非净利润 2.18亿元，同比上升50.77%；负债率33.87%，投资收益3323.27万元，财务费用-20 ...

证券之星消息，截至2026年1月23日收盘，稳健医疗(300888)报收于36.94元，上涨1.4%，换手率 0.87%，成交量5.08万手，成交额1.87亿元。 该股最近90天内共有22家机构给出评级，买入评级18家，增持评级4家；过去90天内机构目标均价为 54.88。 资金流向名词解释：指通过价格变化反推资金流向。股价处于上升状态时主动性买单形成的成交额是推 动股价上涨的力量，这部分成交额被定义为资金流入，股价处于下跌状态时主动性卖单产生的的成交额 是推动股价下跌的力量，这部分成交额被定义为资金流出。当天两者的差额即是当天两种力量相抵之后 剩下的推动股价上升的净力。通过逐笔交易单成交金额计算主力资金流向、游资资金流向和散户资金流 向。 注：主力资金为特大单成交，游资为大单成交，散户为中小单成交 该股主要指标及行业内排名如下： 稳健医疗2025年三季报显示，前三季度公司主营收入78.97亿元，同比上升30.1%；归母净利润7.32亿 元，同比上升32.36%；扣非净利润6.79亿元，同比上升43.93%；其中2025年第三季度，公司单季度主营 收入26.01亿元，同比上升27.71%；单季度归母净利润2. ...

Group 1 - The core viewpoint of the news is that Steady Medical (300888) has shown significant growth in its financial performance, with a notable increase in revenue and net profit for the first three quarters of 2025 compared to the previous year [2] - As of January 19, 2026, Steady Medical's stock closed at 36.55 yuan, with a slight increase of 0.55% and a trading volume of 61,600 lots, amounting to a total transaction value of 225 million yuan [1] - The company reported a main business revenue of 7.897 billion yuan for the first three quarters of 2025, representing a year-on-year increase of 30.1%, and a net profit attributable to shareholders of 732 million yuan, up 32.36% year-on-year [2] Group 2 - In the third quarter of 2025, the company achieved a single-quarter main business revenue of 2.601 billion yuan, which is a 27.71% increase year-on-year, and a net profit of 240 million yuan, reflecting a 42.11% year-on-year growth [2] - The company has a debt ratio of 33.87% and reported investment income of 33.23 million yuan, with financial expenses of -2.036 million yuan, indicating a strong financial position [2] - The gross profit margin for Steady Medical stands at 48.32%, showcasing its efficiency in managing production costs [2]

该股主要指标及行业内排名如下： 稳健医疗2025年三季报显示，前三季度公司主营收入78.97亿元，同比上升30.1%；归母净利润7.32亿 元，同比上升32.36%；扣非净利润6.79亿元，同比上升43.93%；其中2025年第三季度，公司单季度主营 收入26.01亿元，同比上升27.71%；单季度归母净利润2.4亿元，同比上升42.11%；单季度扣非净利润 2.18亿元，同比上升50.77%；负债率33.87%，投资收益3323.27万元，财务费用-203.6万元，毛利率 48.32%。稳健医疗（300888）主营业务：棉类制品的研发、生产、销售,覆盖医疗卫生、个人护理、家 庭护理、母婴护理、家纺服饰等。 该股最近90天内共有22家机构给出评级，买入评级18家，增持评级4家；过去90天内机构目标均价为 54.88。 证券之星消息，截至2026年1月14日收盘，稳健医疗(300888)报收于39.49元，下跌0.23%，换手率 1.36%，成交量7.91万手，成交额3.14亿元。 1月14日的资金流向数据方面，主力资金净流出357.24万元，占总成交额1.14%，游资资金净流出153.44 万元，占总成交额0 ...

证券之星消息，截至2026年1月12日收盘，稳健医疗(300888)报收于39.73元，上涨1.43%，换手率 1.03%，成交量5.98万手，成交额2.36亿元。 1月12日的资金流向数据方面，主力资金净流出293.22万元，占总成交额1.24%，游资资金净流出6.78万 元，占总成交额0.03%，散户资金净流入300.0万元，占总成交额1.27%。 近5日资金流向一览见下表： 稳健医疗2025年三季报显示，前三季度公司主营收入78.97亿元，同比上升30.1%；归母净利润7.32亿 元，同比上升32.36%；扣非净利润6.79亿元，同比上升43.93%；其中2025年第三季度，公司单季度主营 收入26.01亿元，同比上升27.71%；单季度归母净利润2.4亿元，同比上升42.11%；单季度扣非净利润 2.18亿元，同比上升50.77%；负债率33.87%，投资收益3323.27万元，财务费用-203.6万元，毛利率 48.32%。稳健医疗（300888）主营业务：棉类制品的研发、生产、销售,覆盖医疗卫生、个人护理、家 庭护理、母婴护理、家纺服饰等。 该股最近90天内共有22家机构给出评级，买入评级18家， ...

证券之星消息，截至2026年1月9日收盘，稳健医疗(300888)报收于39.17元，上涨1.03%，换手率 0.73%，成交量4.26万手，成交额1.66亿元。 1月9日的资金流向数据方面，主力资金净流出268.42万元，占总成交额1.62%，游资资金净流出660.0万 元，占总成交额3.98%，散户资金净流入928.41万元，占总成交额5.59%。 近5日资金流向一览见下表： 该股主要指标及行业内排名如下： 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 稳健医疗2025年三季报显示，前三季度公司主营收入78.97亿元，同比上升30.1%；归母净利润7.32亿 元，同比上升32.36%；扣非净利润6.79亿元，同比上升43.93%；其中2025年第三季度，公司单季度主营 收入26.01亿元，同比上升27.71%；单季度归母净利润2.4亿元，同比上升42.11%；单季度扣非净利润 2.18亿元，同比上升50.77%；负债率33.87%，投资收益3323.27万元，财务费用-203.6万元，毛利率 48.32%。稳健医疗（30088 ...